ProfileGDS4718 / 217700_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 67% 61% 64% 63% 56% 57% 66% 67% 62% 59% 63% 63% 58% 59% 63% 62% 61% 59% 75% 66% 59% 64% 63% 61% 52% 63% 59% 66% 60% 59% 55% 69% 64% 58% 61% 60% 63% 65% 58% 64% 63% 53% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6502567
GSM549102patient 115, normal, homogenized [OPG study]6.648667
GSM549104patient 119, normal, homogenized [OPG study]6.2439961
GSM549108patient 138, normal, homogenized [OPG study]6.4420364
GSM549119patient 077, normal, homogenized [OPG study]6.358663
GSM549133patient 032, cancer, homogenized [OPG study]5.8655756
GSM549139patient 042, cancer, homogenized [OPG study]5.8921157
GSM549099patient 107, normal, homogenized [OPG study]6.5302266
GSM549109patient 139, normal, homogenized [OPG study]6.6032667
GSM549110patient 046, normal, homogenized [OPG study]6.2821162
GSM549114patient 063, normal, homogenized [OPG study]6.0021959
GSM549122patient 082, normal, homogenized [OPG study]6.3539563
GSM549134patient 033, cancer, homogenized [OPG study]6.319963
GSM549136patient 036, cancer, homogenized [OPG study]5.9901458
GSM549140patient 044, cancer, homogenized [OPG study]6.0142959
GSM549111patient 047, normal, homogenized [OPG study]6.3178163
GSM549113patient 057, normal, homogenized [OPG study]6.2641962
GSM549132patient 031, cancer, homogenized [OPG study]6.179661
GSM549137patient 038, cancer, homogenized [OPG study]6.0909759
GSM549142patient 047, cancer, homogenized [OPG study]7.2222675
GSM549100patient 110, normal, homogenized [OPG study]6.5503566
GSM549107patient 135, normal, homogenized [OPG study]6.029159
GSM549115patient 068, normal, homogenized [OPG study]6.4387864
GSM549116patient 072, normal, homogenized [OPG study]6.3225163
GSM549120patient 078, normal, homogenized [OPG study]6.1979461
GSM549131patient 030, cancer, homogenized [OPG study]5.5819252
GSM549118patient 074, normal, homogenized [OPG study]6.3750463
GSM549129patient 027, cancer, homogenized [OPG study]6.1105959
GSM549123patient 088, normal, homogenized [OPG study]6.5366566
GSM549124patient 006, cancer, homogenized [OPG study]6.1299360
GSM549126patient 015, cancer, homogenized [OPG study]6.0458559
GSM549128patient 025, cancer, homogenized [OPG study]5.8262755
GSM549103patient 117, normal, homogenized [OPG study]6.7819369
GSM549117patient 073, normal, homogenized [OPG study]6.3595664
GSM549138patient 041, cancer, homogenized [OPG study]6.0124158
GSM549141patient 045, cancer, homogenized [OPG study]6.2220961
GSM549130patient 028, cancer, homogenized [OPG study]6.1538760
GSM549101patient 111, normal, homogenized [OPG study]6.3552663
GSM549105patient 128, normal, homogenized [OPG study]6.4523665
GSM549106patient 134, normal, homogenized [OPG study]5.9692158
GSM549112patient 048, normal, homogenized [OPG study]6.4304864
GSM549125patient 011, cancer, homogenized [OPG study]6.3418563
GSM549127patient 024, cancer, homogenized [OPG study]5.7327153
GSM549135patient 035, cancer, homogenized [OPG study]5.9460557